Written answers
Thursday, 3 April 2014
Department of Health
Primary Care Reimbursement Service Payments
Aengus Ó Snodaigh (Dublin South Central, Sinn Fein)
Link to this: Individually | In context | Oireachtas source
244. To ask the Minister for Health if consideration has been given to making the new drug in the treatment of hepatitis C, Telebiron or Vivtielis available to sufferers in the State; and if he will make a statement on the matter. [15774/14]
Aengus Ó Snodaigh (Dublin South Central, Sinn Fein)
Link to this: Individually | In context | Oireachtas source
256. To ask the Minister for Health the reason the drugs Telebiron and Vivtielis are not available to hepatitis C sufferers; and if there are plans to make these drugs available in the future. [15858/14]
Alex White (Dublin South, Labour)
Link to this: Individually | In context | Oireachtas source
I propose to take Questions Nos. 244 and 256 together.
It is assumed the Deputy is referring to Telaprevir (Incivo) and Victrelis (Boceprevir). These drugs are currently available via the Primary Care Reimbursement Service Hepatitis C Reimbursement System, when prescribed via the eight National designated Hepatitis C centres.
No comments